Researchers at the Englander Institute for Precision Medicine (EIPM) bring together basic science, medicine, DNA sequencing and big data to deliver the next generation of precision medicine; the most promising approach to tackle diseases that have thus far eluded effective treatments like cancer, neurodegenerative diseases, and rare genetic conditions.

This process is very data-intensive involving integrating terabytes of information generated from genomic sequencing...